Coexistence of multiple myeloma and Kaposi Sarcoma in a patient with rheumatoid arthritis
DOI:
https://doi.org/10.66344/jpad.30.2.2020.1424Keywords:
Multiple Myeloma, Kaposi Sarcoma, Rheumatoid ArthritisAbstract
Kaposi sarcoma (KS) is a neoplasm of factor VIII-producing endothelial cell origin with inflammatory basis. KS has gained much attention following its prevalence among patients with acquired immune deficiency syndrome (AIDS).1 KS is classified into four epidemiologic forms including classic, African, AIDS associated and iatrogenic. Iatrogenic KS is a subtype of KS, commonly developed among medically immunosuppressed patients. One of the autoimmune diseases which might be associated with KS due to immunosuppression is Rheumatoid arthritis (RA). RA is a systemic autoimmune disorder which affects synovial membrane of multiple joints and requires long term medical treatments with immunosuppressive drugs.2 On the other hand, associations of specific malignancies are also reported in those RA patients, under treatments with methotrexate or immunomodulatory drugs. Here we present a patient diagnosed and treated with RA who later developed multiple myeloma (MM) and KS.ÂReferences
Cesarman E, Damania B, Krown SE, Martin J, Bower M, Whitby D. Kaposi sarcoma. Nat Rev Dis Primers. 2019; 5: 9.
Smolen JS, Breedveld FC, Burmester GR, Bykerk V, Dougados M, Emery P, et al. Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. Ann Rheum Dis. 2016; 75: 3-15.
Mellemkjaer L, Linet M, Gridley G, Frisch M, Møller H, Olsen J. Rheumatoid arthritis and cancer risk. Eur J Cancer. 1996; 32: 1753-7.
Gridley G, McLaughlin JK, Ekbom A, Klareskog L, Adami H-O, Hacker DG, et al. Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst. 1993; 85: 307-11.
Sekiguchi Y, Shimada A, Ichikawa K, Wakabayashi M, Sugimoto K, Ikeda K, et al. Epstein-Barr virus-positive multiple myeloma developing after immunosuppressant therapy for rheumatoid arthritis: a case report and review of literature. In J clin Exp Pathol. 2015; 8: 2090.
Bergler-Czop B, Brzezińska-Wcisło L, Kolanko M. Iatrogenic Kaposi's sarcoma following therapy for rheumatoid arthritis. Adv Dermatol Allergol. 2016; 33: 149.
Philibert P, Chiche L, Caillères S, Allemand J, Rebaudet S, Delord M, et al. HHV8 and Kaposi's sarcoma: should we really give up protease inhibitors in all HIV-infected patients? AIDS. 2017; 31: 2167-9.
Sadeghian MH, Rezaei Dezaki Z, Shams SF, Shakeri S. Correlation between Human Herpes virus 8 (HHV8-) and Plasma Cell Myeloma: a Systematic Review. Rev Clin Med. 2018; 5: 95-100.
Schottstaedt MW, Hurd ER, Stone MJ. Kaposi's sarcoma in rheumatoid arthritis. Am J Med. 1987; 82: 1021-6.
Olivo D, Grembiale R, Tallarigo F, Russo E, De Sarro G, Ursini F. Kaposi's sarcoma after T-cell costimulation blockade with abatacept in rheumatoid arthritis: a case report. J Clin Pharm Ther. 2017; 42: 367-9.
Cohen J, Thomas E, Garnier N, Hellier I, Durand L, Guilhou J, et al. Association of Kaposi sarcoma--multiple myeloma. A new case. Rev Med interne. 2000; 21: 998-1000.
Downloads
Published
How to Cite
Issue
Section
License
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
